Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
---|
02/22/2005 | US6858584 For therapy of bacterial disease in a mammal; side effect reduction |
02/22/2005 | US6858386 Using cancer marker protein to detect, classify, evaluate and prevent cell proliferative disorders |
02/22/2005 | US6858187 Apparatus for the preparation of a radioactive aqueous solution |
02/17/2005 | WO2005015155A2 Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol |
02/17/2005 | WO2005014479A2 Process for preparing radiolabeled compounds |
02/17/2005 | WO2005014052A1 Radioimmunoconjugates for targeted alpha therapy |
02/17/2005 | WO2005014051A1 Emulsion particles for imaging and therapy and methods of use thereof |
02/17/2005 | WO2005013897A2 Magnetic nanoparticle compositions, and methods related thereto |
02/17/2005 | WO2004028338A3 A method to demonstrate the efficacy of pharmacological stress agent |
02/17/2005 | US20050037005 5c8 Antigen |
02/17/2005 | US20050036948 Radiolabeled annexins |
02/17/2005 | CA2536659A1 Process |
02/17/2005 | CA2534687A1 Magnetic nanoparticle compositions, and methods related thereto |
02/17/2005 | CA2534426A1 Emulsion particles for imaging and therapy and methods of use thereof |
02/16/2005 | EP1506027A1 Cell delivery fluid for prevention of cell settling in delivery system |
02/16/2005 | EP1506018A1 Drug pre-targeting by means of bi-specific antibodies and hapten constructs comprising a carrier peptide and the active agent(s) |
02/16/2005 | EP1505973A2 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
02/16/2005 | EP1505955A1 Short chain polymer for enhancing the bioadhesiveness of polymers on mucosal membrane |
02/16/2005 | CN1582166A Vitronectin receptor antagonist pharmaceuticals for use in combination therapy |
02/15/2005 | US6855810 Ligands directed to the non-secretory component, non-stalk region of plgR and methods of use thereof |
02/15/2005 | US6855309 For use in diagnostics and therapy |
02/15/2005 | US6855308 Anticancer, antitumor agents |
02/15/2005 | US6855103 Radioactive implantable devices and methods and apparatuses for their production and use |
02/10/2005 | WO2005012493A2 Anti-cd19 antibodies |
02/10/2005 | WO2005012489A2 Targeting endothelium for tissue-specific delivery of agents |
02/10/2005 | WO2005011738A2 Polymeric conjugates containing phosphine - based chelating groups |
02/10/2005 | WO2005011612A2 Alpha 4 beta 2 delta gaba-a receptors as a strategy for pms and alcoholism |
02/10/2005 | WO2004093856A3 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia |
02/10/2005 | US20050033057 Thiazoline acid derivatives |
02/10/2005 | US20050033048 Spiro[isobenzofuran-1,4'-piperidin]-3-ones and 3h-spiroisobenzofuran-1,4'-piperidines |
02/10/2005 | US20050033030 Humanised antibodies and uses thereof |
02/10/2005 | US20050033026 Immunoconjugates for the treatment of tumours |
02/10/2005 | US20050033024 Expression vector comprising nucleotide sequences coding cytokine receptor for use as tool in identifying modulators for prevention and treatment allergic, skin and respiratory disorders |
02/10/2005 | US20050032789 Novel compounds useful in pain management |
02/10/2005 | US20050032676 Administering lipidated glycopeptide antibiotic and cyclodextrin, reduced tissue accumulation of the glycopeptide antibiotic, reduced nephrotoxicity and reduced histamine release |
02/10/2005 | US20050032148 Diagnostic agents for pancreatic exocrine function |
02/10/2005 | US20050031630 Immunogen (antibody determinant, lipid, peptide, and/or carbohydrate) derived from virus/cancer cell with mast cell membrane activator; microbiocides; wound healing agents; reduced scarring |
02/10/2005 | CA2537899A1 Tissue-specific targeting of therapeutic and imaging agents to caveolae |
02/10/2005 | CA2534639A1 Anti-cd19 antibodies |
02/09/2005 | EP1503805A1 Lyophilized edible food incorporating a marker |
02/09/2005 | EP1503804A1 Radiopharmaceutical formulations |
02/09/2005 | EP1056860B1 High affinity humanized anti-tag-72 monoclonal antibodies |
02/09/2005 | CN1188410C Nonsteroid IL-5 inhibitor, its preparation method and medical composition containing the same inhibitor |
02/08/2005 | US6852842 Methods for functional kidney imaging using small dendrimer contrast agents |
02/03/2005 | WO2005010048A2 Rg1 antibodies and uses thereof |
02/03/2005 | WO2005009963A1 Chelants and macrocyclic metal complex radiopharmaceuticals tihereof |
02/03/2005 | WO2005009597A2 Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol |
02/03/2005 | WO2005009480A2 Implants containing codrugs |
02/03/2005 | WO2005009479A1 Radiolabeled cannabinoid-1 receptor modulators |
02/03/2005 | WO2005009423A1 Necrosis avid tracer agent |
02/03/2005 | WO2005009393A2 Stable radiopharmaceutical compositions and methods for preparation |
02/03/2005 | WO2004071425A3 The combined use of cruciferous indoles and chelators for the treatment of papillomavirus-related conditions |
02/03/2005 | WO2004006860A3 Compositions and uses thereof for identifying and targeting provasopressin-expressing cancer cells |
02/03/2005 | WO2003064606A3 Human monoclonal antibodies to prostate specific membrane antigen (psma) |
02/03/2005 | US20050026955 Radiolabeled piperidine derivatives; chelate compounds; complexes with technetium |
02/03/2005 | US20050026864 Bisphosphonate conjugates and methods of making and using the same |
02/03/2005 | US20050026839 Conformationally constrained parathyroid hormone (pth) analogs |
02/03/2005 | US20050026820 reducing nephrotoxicity; increased therapeutic window for the glycopeptide to allow a greater amount to be administered |
02/03/2005 | US20050026211 Compositions and methods relating to lung specific genes |
02/03/2005 | US20050026178 Allosteric probes and methods |
02/03/2005 | US20050025815 Protonated/acidified nucleic acids are effective as bactericidal and/or bacteriostatic agents |
02/03/2005 | US20050025702 radiotherapeutic or chemotherapeutic agents comprising metalloenzyme inhibitors and chelation compounds capable of conjugating to cytotoxic radioisotopes; anticarcinogenic agents |
02/03/2005 | DE10331439B3 Magnetische Nanopartikel mit verbesserten Magneteigenschaften Magnetic nanoparticles with improved magnetic properties |
02/03/2005 | CA2783275A1 Stable radiopharmaceutical compositions and methods for their preparation |
02/03/2005 | CA2532394A1 Rg1 antibodies and uses thereof |
02/03/2005 | CA2530087A1 Radiolabeled cannabinoid-1 receptor modulators |
02/02/2005 | EP1501554A2 Benzothienyl analogue of somatostatine, selective for certain somatostatin receptors |
02/02/2005 | EP1501551A1 Vitamin-targeted imaging agents |
02/02/2005 | EP1401507A4 Stabilization of radionuclide-containing compositions |
02/02/2005 | EP1131343A4 Hydrophilic somatostatin analogs |
02/02/2005 | CN1575337A Mammalian receptor proteins; related reagents and methods |
02/02/2005 | CN1575302A Human tissue factor antibodies |
02/01/2005 | CA2385369C Radiation source for endovascular radiation treatment in form of a wire |
01/27/2005 | WO2004098650A3 Prosthetic groups attached to stannyl polymer in the synthesis of radiopharmaceuticals |
01/27/2005 | WO2003076565A3 Methods of using 46828, a human acyl-coa synthetase |
01/27/2005 | US20050020931 Management of gastro-intestinal disorders |
01/27/2005 | US20050019845 Immunoconjugates of antibodies and cytotoxic agents (ricin, taxol); for treament of cancer and metastasis; tomography |
01/27/2005 | US20050019257 Radioactive magnetic fluids for treatment or diagnosis of cancer, process for preparing them and use thereof |
01/27/2005 | US20050019254 Combination of intercalating organometallic complexes and tumor seeking biomolecules for dna cleavage and radiotherapy |
01/27/2005 | US20050019253 Using concentration of pancreatic exocrine enzymes visualized by 13C-labeled oligosaccharide or polysaccharide to detect pancreatitis and/or pancreatic cancer |
01/27/2005 | US20050019252 Diagnostic agents for pancreatic exocrine function |
01/27/2005 | US20050019251 Administering isotope labeled water to tissue; measurement; calibration |
01/26/2005 | EP1499730A1 Immunoconjugates for the treatment of tumours |
01/26/2005 | EP1499614A1 Adenosine a3 receptor modulators |
01/26/2005 | EP1499584A2 Tumor imaging compounds |
01/26/2005 | EP1499353A2 Antibodies that specifically bind to tl5 |
01/26/2005 | EP1499351A2 Antibodies that specifically bind to tr2 |
01/26/2005 | EP1307239A4 Radiopharmaceutical for diagnostic imaging containing a technetium-99m nitride heterocomplex |
01/26/2005 | EP1233752B1 Radiation sensitive liposomes |
01/26/2005 | EP0975373B1 Radionuclide associated with nucleotide polyphosphate as tumor imaging agents |
01/26/2005 | CN1571680A PACAP compositions and methods for tumor imaging and therapy |
01/25/2005 | US6846476 Treatment of B-cell associated diseases |
01/25/2005 | CA2123224C Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of t-lymphocytes |
01/20/2005 | WO2005006356A1 Magnetic nanoparticles having improved magnetic properties |
01/20/2005 | WO2005004809A2 Multivalent carriers of bi-specific antibodies |
01/20/2005 | WO2004096292A3 Use of a tetrapeptide acsdkp analogue resistant to the angiotensin i conversion enzyme, for measuring glomerular filtration rate in a human or an animal and kit containing same |
01/20/2005 | WO2004050698A3 Peptide conjugate useful for cell nucleus molecular imaging and tumor therapy |
01/20/2005 | WO2003057155A3 Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factor |
01/20/2005 | US20050014939 E.g., N-[4-(2-Pyrrolidinylethoxy)phenyl]-4-oxo-4,5,6,7-tetrahydro-1H-indole-3-carboxamide; treating diseases associated with pathogenic agonism, inverse agonism or antagonism of the GABAA receptor such as anxiety, depression, a sleep disorder, or cognitive impairment |
01/20/2005 | US20050014693 Transmission and, or amplification of signals; oral or enteric administering, dissolving, absorption of peptide yy; obesity therapy |